Literature DB >> 2269351

Low density lipoprotein activates monocytes to express tumor necrosis factor.

P Barath1, J Cao, J S Forrester.   

Abstract

We analyzed the effect of acetylated low density lipoprotein (aLDL) incubation on tumor necrosis factor (TNF) mRNA and protein expression in isolated resting human monocytes in serum free DMEM. TNF mRNA expression was about one third that of PMA and was dose dependent. The maximum stimulatory effect on TNF mRNA was at 250 micrograms/ml, while 500 micrograms/ml induced downregulation. The maximum stimulatory effect occurred at 6 hours, and by 24 hours TNF mRNA expression returned to the resting state. Acetyl LDL also induced the expression of immunoreactive TNF, reaching a sevenfold maximum above control at 12 hours following a 6 hour exposure period. The results suggest that aLDL is a potent stimulator of TNF expression in resting monocytes. This mechanism may be operational in atheroma evolution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2269351     DOI: 10.1016/0014-5793(90)80838-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Induction of interleukin-1 production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line.

Authors:  T Palkama
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

3.  Regulation of endothelial adhesion molecules by ligands binding to the scavenger receptor.

Authors:  T Palkama; M L Majuri; P Mattila; M Hurme; R Renkonen
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

Review 4.  Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.

Authors:  Maureen McMahon; Bevra H Hahn
Journal:  Curr Opin Immunol       Date:  2007-12       Impact factor: 7.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.